Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
81 Results for "
CD86
" in MedChemExpress (MCE) Product Catalog:
Products (81)
81 Results for "CD86" in MCE Product Catalog:
Cat. No.: HY-P8F031K
Synonyms: CD86,CD86-AF700,BU63
Cat. No.: HY-P8F031L
Synonyms: CD86,CD86-PC Blue,BU63
Cat. No.: HY-P8F065K
Synonyms: CD86,CD86-AF700,GL1
Cat. No.: HY-P8F065L
Synonyms: CD86,CD86-PC Blue,GL1
Cat. No.: HY-P8F031D
Synonyms: CD86,CD86-PE-Cy7,BU63
Cat. No.: HY-P8F031E
Synonyms: CD86,CD86-PE-CF596,BU63
Cat. No.: HY-P8F031J
Synonyms: CD86,CD86-APC-Cy7,BU63
Cat. No.: HY-P8F065D
Synonyms: CD86,CD86-PE-Cy7,GL1
Cat. No.: HY-P8F031G
Synonyms: CD86,CD86-PerCP-Cy5.5,BU63
Cat. No.: HY-P8F065G
Synonyms: CD86,CD86-PerCP-Cy5.5,GL1
Cat. No.: HY-P810806
Synonyms: Interferon gamma; IFN-gamma; Immune interferon
Cat. No.: HY-138794B
CAS No.: 2417089-75-7
Synonyms: (R)-XL177A
Target:
Research Areas:
XL177B is an inactive (R) enantiomer of XL177A (HY-138794). XL177B has no effect on CD86 or HLA-DR expression on pDCs. XL177B serves as a negative control. XL177B can be used in the research of multiple myeloma .
Cat. No.: HY-P86682A
Synonyms: CD28LG2; FUN1; LAB72; Activation B7 2 antigen; Activation B7-2 antigen 3; CD86_HUMAN; Activation B7-2 antigen; Activation B72 antigen; B lymphocyte activation antigen B7 2; B lymphocyte activation antigen B72; B-lymphocyte activation antigen B7-2 2; B-lymphocyte activation antigen B7-2; B7 2; B7 2 antigen; B7; B7-2; B7.2; B70; B72 antigen; BU63; CD 86; CD28 antigen ligand 2 2; CD28 antigen ligand 2; CD28l2; CD28LG2; CD86 antigen(CD28 antigen ligand 2, B7-2 antigen) 1, 2; CD86 antigen; CD86 molecule; CLS1; CTLA 4 counter receptor B7 2; CTLA 4 counter receptor B7.2; CTLA-4 counter-receptor B7.2 2, 3; CTLA4 counter receptor B72; Early T-cell costimulatory molecule 1; ETC-1; FUN 1; LAB72; Ly-58; Ly58; MB7; MB7-2; Membrane glycoprotein; MGC34413; T lymphocyte activation antigen CD86; T-lymphocyte activation antigen CD86; TS/A-2.
Cat. No.: HY-P86682
Synonyms: CD28LG2; FUN1; LAB72; Activation B7 2 antigen; Activation B7-2 antigen 3; CD86_HUMAN; Activation B7-2 antigen; Activation B72 antigen; B lymphocyte activation antigen B7 2; B lymphocyte activation antigen B72; B-lymphocyte activation antigen B7-2 2; B-lymphocyte activation antigen B7-2; B7 2; B7 2 antigen; B7; B7-2; B7.2; B70; B72 antigen; BU63; CD 86; CD28 antigen ligand 2 2; CD28 antigen ligand 2; CD28l2; CD28LG2; CD86 antigen(CD28 antigen ligand 2, B7-2 antigen) 1, 2; CD86 antigen; CD86 molecule; CLS1; CTLA 4 counter receptor B7 2; CTLA 4 counter receptor B7.2; CTLA-4 counter-receptor B7.2 2, 3; CTLA4 counter receptor B72; Early T-cell costimulatory molecule 1; ETC-1; FUN 1; LAB72; Ly-58; Ly58; MB7; MB7-2; Membrane glycoprotein; MGC34413; T lymphocyte activation antigen CD86; T-lymphocyte activation antigen CD86; TS/A-2.
Cat. No.: HY-141677C
CAS No.: 1802909-50-7
Target:
Research Areas:
INCB059872 TFA is a potent, orally active, selective and irreversible Lysine-Specific Demethylase 1 (LSD1) inhibitor that achieves inhibitory activity through the formation of covalent FAD-adducts. INCB059872 TFA can inhibit cell proliferation and induce cell differentiation by upregulating the expression of myeloid differentiation markers CD86 and CD11b. INCB059872 TFA can be used for the research of myeloid leukemia .
Cat. No.: HY-189513
CAS No.: 1291868-53-5
Synonyms: ZINC67299692
Research Areas:
NSF-951 (ZINC67299692) is a TLR4 agonist (Kd = 16.01 μM). NSF-951 activates the p38 and JNK kinase pathways. NSF-951 induces IL-6 and TNF-α responses and upregulates CD80 and CD86 expression. In mouse immunization studies, NSF-951 alone or in combination with Alum enhances antigen-specific antibody and T cell responses .
Cat. No.: HY-P991961
Cat. No.: HY-P992408
Target:
Research Areas:
Cat. No.: HY-P991952
Cat. No.: HY-181781
CAS No.: 3104325-26-7
Target:
Research Areas:
LSD1-IN-48 is a tranylcypromine-pyrimidine derivative and selective LSD1 inhibitor with a human IC50 of 7.87 nM. LSD1-IN-48 increases H3K4me1/2 histone methylation levels. LSD1-IN-48 induces apoptosis, upregulates CD86, downregulates SOX2 and CD44, inhibits proliferation in cancer cells. LSD1-IN-48 can be used for the research of acute myeloid leukemia .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
